Online Database of Chemicals from Around the World

Ifosfamide
[CAS# 84711-20-6]

Suppliers
APIChem Technology Co., Ltd. China Inquire  
+86 (571) 8678-2096
sales@apichemistry.com
Chemical manufacturer since 2009
Abblis Chemicals LLC USA Inquire  
+1 (832) 373-8299
info@abblis.com
Chemical manufacturer
Alfa Chemistry USA Inquire  
+1 (201) 478-8534
inquiry@alfa-chemistry.com
Chemical distributor since 2012
chemBlink standard supplier since 2012
Astatech, Inc. USA Inquire  
+1 (215) 785-3197
sales@astatechinc.com
Chemical manufacturer since 1996
Atomole Scientific Co., Ltd. China Inquire  
+86 (27) 8262-4262
sales@atomole.com
Chemical manufacturer since 2008
AvaChem Scientific LLC USA Inquire  
+1 (210) 667-3815
chemsupply@avachem.com
Chemical manufacturer
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Skype Chat
Chemical distributor
chemBlink massive supplier since 2012
ChemPacific Corp USA Inquire  
+1 (410) 633-5771
sales@chempacific.com
Chemical manufacturer since 1995
ChemScene LLC USA Inquire  
+1 (732) 484-9848
sales@chemscene.com
Chemical manufacturer since 2011
Glentham Life Sciences UK Inquire  
+44 (2033) 978-798
info@glenthamls.com
Chemical distributor since 2013
Identification
Name Ifosfamide
Synonyms N,3-Bis(2-Chloroethyl)-2-Oxo-1-Oxa-3-Aza-2$L^{5}-Phosphacyclohexan-2-Amine; (2R)-N,3-Bis(2-Chloroethyl)-2-Oxo-1-Oxa-3-Aza-2$L^{5}-Phosphacyclohexan-2-Amine; N,3-Bis(2-Chloroethyl)-2-Hydroxy-1,3,2-Oxazaphosphinan-2-Ium-2-Amine
Molecular Structure CAS#: 84711-20-6, Ifosfamide
Molecular Formula C7H15Cl2N2O2P
Molecular Weight 261.09
CAS Registry Number 84711-20-6
SMILES C(N1[P](OCCC1)(NCCCl)=O)CCl
InChI 1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)
InChIKey HOMGKSMUEGBAAB-UHFFFAOYSA-N
Properties
Density 1.334g/cm3 (Cal.)
Boiling point 336.099°C at 760 mmHg (Cal.)
Flash point 157.068°C (Cal.)
References
(1) Kenneth E. Thummel and Danny D. Shen. Percentage Binding in Plasma, "Goodman & Gilman's The Pharmacological Basis of Therapeutics", 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023'Bound in Plasma' (%) values have been taken from the Table A-II-1 given in Appendix II of the above mentioned reference. Users are requested to go through the comments associated with these values, which have been given as footnotes in the table. Only drugs that had 'Bound in Plasma' values indicated for them have been provided in the files here. Structures (and values) for Clavulanate (22), Heparin (Extensive), Lithium (0), Mycophenolate (MPA: 97.5), Prednisolone (90-95 (<200 ng/ml), ~70(>1 microgm/ml)) and Rapacuronium (50-88) have not been provided here. In all, 280 drugs and their 'Bound in Plasma' values (%) are given in the files here.
(2) Kenneth E. Thummel and Danny D. Shen. Peak Time, "Goodman & Gilman's The Pharmacological Basis of Therapeutics", 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023'Peak-Time' values have been taken from the Table A-II-1 given in Appendix II of the above mentioned reference. These are in hours unless otherwise indicated. Users are requested to go through the comments associated with these values, which have been given as footnotes in the table. Only drugs that had 'Peak-Time' values indicated for them have been provided in the files here. Structures (and values) for Clavulanate (1.3), Enoxaparin (3), Epoetin Alfa (SC: 18, IP:12), Etanercept (SC-SD:72(48-96)), Filgrastim (4-5.8), Heparin (3), Interferon Alfa (IM:3.8,SC:7.3), Interferon Beta (SC:1-8), Lithium (IR:0.5-3, SR:2-6), Mycophenolate (MPA: 1.1-2.2), Prednisolone (1.5+-0.5), Sargramostim (A,SC: 1-3, C,SC:1.5-4) and Streptokinase (0.9+-0.21) have not been provided here. In all, 270 drugs and their 'Peak-Time' values are given in the files here.
(3) Kenneth E. Thummel and Danny D. Shen. Urinary Excretion, "Goodman & Gilman's The Pharmacological Basis of Therapeutics", 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023Urinary Excretion (%) values have been taken from the Table A-II-1 given in Appendix II of the above mentioned reference. Users are requested to go through the comments associated with these values, which have been given as footnotes in the table. Only drugs that had Urinary Excretion values indicated for them have been provided in the files here. Structures (and values) for Alteplase (t-PA) (Low), Clavulanate (43+-14), Enoxaparin (43), Epoetin alfa (<3), Etanercept (Negligible), Heparin (Negligible), Lithium (95+-15), Mycophenolate (MPA: <1), Prednisolone (26+-9), Rapacuronium (6-22) and Streptokinase (0) have not been provided here. In all, 297 drugs and their Urinary Excretion values (%) are given in the files here.
(4) Kenneth E. Thummel and Danny D. Shen. Volume of Distribution, "Goodman & Gilman's The Pharmacological Basis of Therapeutics", 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023'Volume of Distribution' values have been taken from the Table A-II-1 given in Appendix II of the above mentioned reference. These are in liters/kg units unless otherwise indicated. Users are requested to go through the comments associated with these values, which have been given as footnotes in the table. Only drugs that had 'Volume of Distribution' values indicated for them have been provided in the files here. Structures (and values) for Alteplase (t-PA) (0.10+-0.01), Clavulanate (0.21+-0.05), Enoxaparin (0.12+-0.04), Epoetin Alfa (0.033+-0.013 (0.033-0.075)), Etanercept (0.11), Filgrastim (0.15), Heparin (0.058+-0.11) +- 0.1), Infliximab (0.043). Interferon Alfa (0.40+-0.19), Interferon Beta (2.9+-1.8), Lithium (0.66+-0.16), Mycophenolate (MPA: 3.6+-4), Prednisolone (0.42+-0.11), Rapacuronium (0.2-0.5), Sargramostim (A: -, C:2(0.4-18) liters/(m.m)) and Streptokinase (0.08+-0.04) have not been provided here. In all, 284 drugs and their 'Volume of Distribution' values are given in the files here.
(5) Kenneth E. Thummel and Danny D. Shen. Peak Concentration, "Goodman & Gilman's The Pharmacological Basis of Therapeutics", 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023'Peak-Concentrations' values have been taken from the Table A-II-1 given in Appendix II of the above mentioned reference. The units are indicated along with the values. Users are requested to go through the comments associated with these values, which have been given as footnotes in the table. Structures (and values) for Alteplase (t-PA) (973+-133 ng/ml), Clavulanate (2.8 micro g/ml), Enoxaparin (ACLM: 145+-45 ng/ml, BCLM: 414+-87 ng/ml), Epoetin Alfa (SC: 176+-75 U/l, IP: 375+-123 U/l), Etanercept (IV:2.32 micro-g/ml, SC-SD:1.2 micro-g/ml, SC-MD 3 micro-g/ml), Filgrastim (SC: 4 and 49 ng/ml), Heparin (70+-39 ng/ml), Infliximab (118 micro-g/ml), Interferon Alfa (IV: ~13 ng/ml, IM: 2.0 (1.5-2.6) ng/ml, SC: 1.7 (1.2-2.3) ng/ml), Interferon Beta (IV: 1491+-659 IU/ml, SC: 40+-20 IU/ml), Lithium (IR: 1-2 mM, SR: 0.7-1.2 mM), Mycophenolate (MPA: 8-19 micro-g/ml), Prednisolone (458+-150 ng/ml), Rapacuronium (6-20 micro-g/ml), Sargramostim (A, IV: 5ng/ml, A, SC: 1.5 ng/ml, C, IV: 100 ng/ml, C, SC: 10 ng/ml) and Streptokinase (188+-58 IU/ml) have not been provided here. In all, 304 drugs and their 'Peak-Concentration' values are given in the files here.
Market Analysis Reports
List of Reports Available for Ifosfamide
Related Products
6-Chloro-N2-Cyclohexyl-N4-(3-Methoxyprop...  N'-[3-[[[[Bis(1-Methylethyl)Amino]Carbon...  1,2-Benzenedicarboxylic acid, 1-(2-ethox...  Racefenicol  Bis(2-Hydroxyethyl) Phthalate  4-(5-Ethyl-1,3-Dioxan-2-Yl)Benzonitrile  1-(4-Amino-3-Fluoro-5-Iodophenyl)Ethan-1...  5-[3-[(1,1-Dimethylethyl)Amino]-2-Hydrox...  2-Acetyl-1-Oleoylglycerol  Methionyl-asparaginyl-tyrosyl-leucyl-ala...  1,3-Bis(2-Ethylhexyl)Cyclohexane  3-(2,3-Dimethylphenyl)-2-Hydrazinyl-4(3H...  3-(2,3-Dimethyl-Phenyl)-2-Mercapto-3H-Qu...  3-(3,4-Dimethyl-Phenyl)-2-Mercapto-3H-Qu...  3-Chloro-4-(Trifluoromethyl)Phenylboroni...